Cleared Traditional

K182130 - iSchemaView RAPID

K182130 is the FDA 510(k) clearance for iSchemaView RAPID by Ischemaview, Inc.. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 143-day FDA review.

K182130 · Ischemaview, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2018
Decision
143d
Days
Class 2
Risk

K182130 is an FDA 510(k) clearance for the iSchemaView RAPID. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Ischemaview, Inc. (Redwood City, US). The FDA issued a Cleared decision on December 27, 2018 after a review of 143 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Ischemaview, Inc. devices

Submission Details

510(k) Number K182130 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 06, 2018
Decision Date December 27, 2018
Days to Decision 143 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
36d slower than avg
Panel avg: 107d · This submission: 143d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1055
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K182130.
MRCP+ v1.0
K183133 · Perspectum Diagnostics, Ltd. · Jan 2019
ProKnow DS
K182855 · Proknow, LLC · Jan 2019
AmCAD-UO
K180867 · Amcad Biomed Corporation · Dec 2018
Quantib ND
K182564 · Quantib B.V. · Dec 2018
4D View
K182750 · GE Medical Systems Ultrasound and Primary Care Diagnostics · Dec 2018
vascuCAP
K183012 · Elucid Bioimaging, Inc. · Dec 2018